Resverlogix (RVX) News Today C$0.06 0.00 (0.00%) (As of 12:24 PM ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsHeadlinesInsider Trades All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period New beanless 'coffee' emerges but does it taste any good?September 17, 2024 | bbc.comNumerous Independent Groups Presented Data that Supports Apabetalone’s Potential Cardioprotective Benefits at European Society of Cardiology Congress 2024September 3, 2024 | msn.comResverlogix: Top 10 Undervalued Biotechnology Industry Stocks (RVX)September 3, 2024 | theglobeandmail.comResverlogix Corp. (RVXCF)July 31, 2024 | finance.yahoo.comResverlogix Announces Voting Results from the 2024 Meeting of Shareholders and Closing of Debenture ExtensionJuly 31, 2024 | finance.yahoo.comClosing Bell: Resverlogix Corp up on Tuesday (RVX)July 28, 2024 | theglobeandmail.comClosing Bell: Resverlogix Corp flat on Wednesday (RVX)July 25, 2024 | theglobeandmail.comResverlogix Announces Updated Annual and Special Meeting of ShareholdersMay 28, 2024 | finance.yahoo.comResverlogix Corp. (RVX.TO)May 16, 2024 | finance.yahoo.comResverlogix Announces Two-Year Extension of Debenture and Elimination of Conversion PrivilegesMay 13, 2024 | finance.yahoo.comResverlogix Announces Change to Its Board of DirectorsFebruary 21, 2024 | finance.yahoo.comResverlogix Announces Publication of its 40th Scientific Journal Article on Apabetalone's Potential Therapeutic BenefitsJanuary 11, 2024 | finance.yahoo.comClosing Bell: Resverlogix Corp flat on Tuesday (RVX)January 4, 2024 | theglobeandmail.comResverlogix Corp. (RVX) Earnings Dates & ReportsDecember 19, 2023 | investing.comResverlogix Corp RVXCFNovember 18, 2023 | morningstar.comResverlogix Corp RVXNovember 1, 2023 | morningstar.comResverlogix: Top 10 Undervalued Healthcare Sector Stocks on TSX (RVX)October 18, 2023 | theglobeandmail.comResverlogix Corp.: Resverlogix Publishes on Apabetalone's Potential for the Treatment of FSHD, the Third Most Common Muscular DystrophyOctober 4, 2023 | finanznachrichten.deResverlogix Publishes on Apabetalone's Potential for the Treatment of FSHD, the Third Most Common Muscular DystrophyOctober 4, 2023 | finance.yahoo.comAtherosclerotic Cardiovascular Disease Market to Observe Impressive Growth at a CAGR of 2.2% by 2032, Predicts DelveInsightSeptember 26, 2023 | finance.yahoo.comResverlogix Announces a Favorable Outlook Based on New Cardiovascular Disease Treatment Guidelines for Patients with Type 2 DiabetesAugust 29, 2023 | finance.yahoo.comClosing Bell: Resverlogix Corp up on Wednesday (RVX)August 24, 2023 | theglobeandmail.comClosing Bell: Resverlogix Corp flat on Monday (RVX)August 14, 2023 | theglobeandmail.comClosing Bell: Resverlogix Corp Warrants down on Wednesday (RVX-WT-A)July 12, 2023 | theglobeandmail.comResverlogix Announces Warrant Repricing and One-Year ExtensionJune 29, 2023 | finance.yahoo.comResverlogix Corp.: Resverlogix Announces Voting Results from the 2023 Meeting of ShareholdersJune 20, 2023 | finanznachrichten.deResverlogix Announces Voting Results from the 2023 Meeting of ShareholdersJune 20, 2023 | finance.yahoo.comResverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease PatientsJune 12, 2023 | finance.yahoo.comCanadian Investment Regulatory Organization Trading Halt - RVX.WT.AJune 7, 2023 | finance.yahoo.comClosing Bell: Resverlogix Corp Warrants down on Friday (RVX-WT-A)June 6, 2023 | theglobeandmail.comClosing Bell: Resverlogix Corp Warrants down on Tuesday (RVX-WT-A)May 25, 2023 | theglobeandmail.comCBOE RUSSELL 2000 VOLATILITY IN (^RVX)May 18, 2023 | finance.yahoo.comClosing Bell: Resverlogix Corp down on Monday (RVX)May 2, 2023 | theglobeandmail.comClosing Bell: Resverlogix Corp flat on Friday (RVX)April 29, 2023 | theglobeandmail.comClosing Bell: Resverlogix Corp Warrants flat on Thursday (RVX-WT-A)April 28, 2023 | theglobeandmail.comClosing Bell: Resverlogix Corp up on Thursday (RVX)April 27, 2023 | theglobeandmail.comClosing Bell: Resverlogix Corp down on Wednesday (RVX)April 27, 2023 | theglobeandmail.comClosing Bell: Resverlogix Corp down on Tuesday (RVX)April 25, 2023 | theglobeandmail.comClosing Bell: Resverlogix Corp down on Friday (RVX)April 22, 2023 | theglobeandmail.comClosing Bell: Resverlogix Corp Warrants flat on Friday (RVX-WT-A)April 18, 2023 | theglobeandmail.comClosing Bell: Resverlogix Corp up on Friday (RVX)April 15, 2023 | theglobeandmail.comClosing Bell: Resverlogix Corp Warrants flat on Wednesday (RVX-WT-A)April 13, 2023 | theglobeandmail.comClosing Bell: Resverlogix Corp Warrants flat on Wednesday (RVX-WT-A)April 13, 2023 | theglobeandmail.comClosing Bell: Resverlogix Corp Warrants flat on Tuesday (RVX-WT-A)April 13, 2023 | theglobeandmail.comClosing Bell: Resverlogix Corp Warrants flat on Monday (RVX-WT-A)April 12, 2023 | theglobeandmail.comClosing Bell: Resverlogix Corp down on Thursday (RVX)April 8, 2023 | theglobeandmail.comResverlogix extends debenture maturity by one yearMarch 20, 2023 | msn.comResverlogix Announces New Research Highlighting Apabetalone's Potential Benefits in Cardiovascular Disease, Heart Failure, and COVID-19March 2, 2023 | finance.yahoo.comInsiders who bought in the last 12 months lose an additional US$43k as Resverlogix Corp. (TSE:RVX) drops to CA$44mDecember 11, 2022 | finance.yahoo.comInvestmentPitch Media Video Discusses Resverlogix and its Focus on Apabetalone's Future Development for the Prevention and Treatment of Post COVID-19 Conditions - GlobeNewswireSeptember 30, 2022 | globenewswire.com Get Resverlogix News Delivered to You Automatically Sign up to receive the latest news and ratings for RVX and its competitors with MarketBeat's FREE daily newsletter. Email Address [625,000% Gain] – Are You Ready for the Next Altcoin Boom? (Ad)All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen. Register for the FREE Workshop Now & get $10 in Bitcoin RVX Media Mentions By Week RVX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RVX News Sentiment▼1.380.47▲Average Medical News Sentiment RVX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RVX Articles This Week▼00▲RVX Articles Average Week Get Resverlogix News Delivered to You Automatically Sign up to receive the latest news and ratings for RVX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Microbix Biosystems News Today Aeterna Zentaris News Today Sirona Biochem News Today Kane Biotech News Today Hemostemix News Today Innovotech News Today Aptose Biosciences News Today Quest PharmaTech News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (TSE:RVX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Resverlogix Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Resverlogix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
